SCHEMBL18319286

SCHEMBL18319286

NNc1ccccc1Oc1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.50
SLC6A4 P31645 3/20 0.50
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
ALDH1A1 P00352 4/20 0.46
NPSR1 Q6W5P4 4/20 0.46
ALOX12 P18054 2/20 0.46
GPR55 Q9Y2T6 1/20 0.46
MAPT P10636 4/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30490051 1.00 HTR2A (0.50) HTR2ASLC6A4SLC6A2SLC6A3HTT
SCHEMBL2000120 0.84 TSHR (0.58) L3MBTL1TDP1ALDH1A1NPSR1KMT2A
Hydrochloric Acid SCHEMBL4382625 0.82 TSHR (0.56) L3MBTL1TDP1ALDH1A1NPSR1ALOX12
SCHEMBL18319346 0.81 HTR2A (0.50) HTR2ASLC6A4HTTL3MBTL1TDP1
SCHEMBL30490050 0.81 SLC6A2 (0.46) SLC6A4SLC6A2SLC6A3HTTL3MBTL1
SCHEMBL30490056 0.81 HTR2A (0.50) HTR2ASLC6A4HTTL3MBTL1TDP1
SCHEMBL30490055 0.81 ALDH1A1 (0.53) SLC6A4SLC6A2SLC6A3HTTL3MBTL1
SCHEMBL11158176 0.78 NPSR1 (0.57) HTR2ASLC6A4HTTL3MBTL1TDP1
SCHEMBL16296139 0.77 RHEB (0.47) SLC6A4SLC6A2SLC6A3TDP1ALDH1A1
SCHEMBL18319356 0.77 CACNA1B (0.49) L3MBTL1TDP1ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3112343-B1 AMIDE DERIVATIVES UNIV TOHOKU (JP) 2023-03-29 EP disclosed
US-11040937-B2 Amide derivative TOHOKU UNIVERSITY (JP) 2021-06-22 US disclosed
CN-106029632-B Amide derivatives 国立大学法人东北大学 2019-06-21 CN disclosed
EP-3112343-A1 AMIDE DERIVATIVES Tohoku University (JP) 2017-01-04 EP disclosed
US-20160368860-A1 AMIDE DERIVATIVE TOHOKU UNIVERSITY (JP) 2016-12-22 US disclosed
CN-106029632-A Amide derivatives 国立大学法人东北大学 2016-10-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160368860-A1 AMIDE DERIVATIVE ARG1, PTMS, MLX HTR2A 4028/4885SLC6A4 2674/4885SLC6A2 2241/4885
US-11040937-B2 Amide derivative ARG1, PTMS, MLX HTR2A 4028/4885SLC6A4 2674/4885SLC6A2 2241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.